Creative Planning - EDITAS MEDICINE INC ownership

EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 229 filers reported holding EDITAS MEDICINE INC in Q4 2019. The put-call ratio across all filers is 2.01 and the average weighting 0.1%.

Quarter-by-quarter ownership
Creative Planning ownership history of EDITAS MEDICINE INC
ValueSharesWeighting
Q1 2022$5,000
-97.6%
250
-93.3%
0.00%
Q2 2021$212,000
-70.3%
3,736
-78.1%
0.00%
-100.0%
Q1 2021$715,000
-12.5%
17,035
+43.1%
0.00%
-50.0%
Q4 2020$817,000
+88.7%
11,901
-25.0%
0.00%
+100.0%
Q3 2020$433,000
-4.8%
15,869
+3.1%
0.00%0.0%
Q2 2020$455,000
-39.7%
15,397
-59.6%
0.00%
-66.7%
Q1 2020$755,000
-49.6%
38,067
-24.7%
0.00%
-25.0%
Q4 2019$1,497,000
+100.7%
50,572
+54.1%
0.00%
+100.0%
Q3 2019$746,000
-10.1%
32,814
-2.2%
0.00%
-33.3%
Q2 2019$830,000
+28.1%
33,564
+26.6%
0.00%
+50.0%
Q1 2019$648,000
+15.7%
26,504
+7.6%
0.00%0.0%
Q4 2018$560,000
-29.2%
24,625
-0.9%
0.00%
-33.3%
Q3 2018$791,000
-11.1%
24,858
+0.1%
0.00%0.0%
Q2 2018$890,000
+3.0%
24,830
-4.7%
0.00%
-25.0%
Q1 2018$864,000
+19.5%
26,057
+10.8%
0.00%
+33.3%
Q4 2017$723,000
+227.1%
23,525
+155.5%
0.00%
+200.0%
Q3 2017$221,000
+44.4%
9,207
+1.2%
0.00%0.0%
Q2 2017$153,000
+7550.0%
9,101
+8910.9%
0.00%
Q1 2017$2,000
-96.4%
101
-97.1%
0.00%
Q4 2016$56,0003,440
+343900.0%
0.00%
Q3 2016$0
-100.0%
1
-99.9%
0.00%
Q2 2016$39,000
+178.6%
1,601
+299.3%
0.00%
Q1 2016$14,0004010.00%
Other shareholders
EDITAS MEDICINE INC shareholders Q4 2019
NameSharesValueWeighting ↓
ARK Investment Management 3,024,489$68,807,0002.79%
Wildcat Capital Management, LLC 185,668$4,224,0002.78%
Casdin Capital, LLC 480,000$10,920,0001.87%
Elmwood Wealth Management, Inc. 80,381$1,829,0001.77%
JS Capital Management LLC 218,935$4,981,0001.42%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,158,841$26,364,0001.06%
Valiant Capital Management, L.P. 379,800$8,640,0000.81%
Capital Impact Advisors, LLC 63,637$1,319,0000.56%
Global Thematic Partners, LLC 439,757$10,004,0000.54%
ONTARIO TEACHERS PENSION PLAN BOARD 867,966$19,746,0000.49%
View complete list of EDITAS MEDICINE INC shareholders